Home

Pablo G. Legorreta

CIK 1507678 · CEO, Chairman of the Board · last filed 2026-08-07

Pablo G. Legorreta is a CEO, Chairman of the Board who has filed 26 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for RPRX, was dated Aug 7, 2026. Across all open-market trades the lifetime net is +$19.6M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $136.7M across reported positions. 7 SEC filings were submitted jointly with RP Management, LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$136.69M

Companies

3

Total Filings

26

Lifetime Open-Market Net

$19.59M

Filer Profile

Reported Address
110 E 59TH STREET
SUITE 3300
NEW YORK, NY 10022
Related Filers
RP Management, LLC — 7 joint filings, latest 2022-08-16
Tolerantia, LLC — 7 joint filings, latest 2025-06-05
Pharma Investments 2019 ICAV Royalty — 2 joint filings, latest 2022-08-16
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RPRX CEO, Chairman of the Board 1,426,320 $63.96 $91.23M $19.59M 19 2026-08-07
PROK Director 22,617,909 $2.01 $45.46M $0 5 2026-05-29
Epizyme, Inc. (EPZM) Delisted Director 9,166,667 $1.47 $13.48M $0 2 2020-06-02

Recent Filings

26 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-07 RPRX Mixed +65,216 $0 EDGAR
2026-08-07 RPRX Mixed +65,216 $0 EDGAR
2026-05-29 PROK Grant (A) — $0 EDGAR
2026-05-08 RPRX Grant (A) +143,821 $0 EDGAR
2026-02-13 RPRX Grant (A) +157,828 $0 EDGAR
2025-11-07 RPRX Grant (A) +36,559 $0 EDGAR
2025-08-08 RPRX Mixed +21,901 $0 EDGAR
2025-06-02 PROK Grant (A) — $0 EDGAR
2025-05-20 RPRX Mixed +530,348 $0 EDGAR
2025-05-14 RPRX Gift (G) — $0 EDGAR
Showing 1–10 of 26
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.